Codexis, Inc. (CDXS)
NASDAQ: CDXS · IEX Real-Time Price · USD
3.550
+0.250 (7.58%)
At close: Jul 19, 2024, 4:00 PM
3.670
+0.120 (3.38%)
Pre-market: Jul 22, 2024, 7:32 AM EDT
Codexis Revenue
Codexis had revenue of $74.23M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $17.07M with 31.51% year-over-year growth. In the year 2023, Codexis had annual revenue of $70.14M.
Revenue (ttm)
$74.23M
Revenue Growth
-36.13%
P/S Ratio
3.37
Revenue / Employee
$426,632
Employees
174
Market Cap
250.48M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 70.14M | -68.45M | -49.39% |
Dec 31, 2022 | 138.59M | 33.84M | 32.30% |
Dec 31, 2021 | 104.75M | 35.70M | 51.69% |
Dec 31, 2020 | 69.06M | 598.00K | 0.87% |
Dec 31, 2019 | 68.46M | 7.86M | 12.98% |
Dec 31, 2018 | 60.59M | 10.57M | 21.13% |
Dec 31, 2017 | 50.02M | 1.19M | 2.43% |
Dec 31, 2016 | 48.84M | 7.03M | 16.82% |
Dec 31, 2015 | 41.80M | 6.50M | 18.40% |
Dec 31, 2014 | 35.31M | 3.39M | 10.60% |
Dec 31, 2013 | 31.92M | -56.38M | -63.85% |
Dec 31, 2012 | 88.30M | -35.57M | -28.71% |
Dec 31, 2011 | 123.87M | 16.76M | 15.65% |
Dec 31, 2010 | 107.10M | 24.20M | 29.18% |
Dec 31, 2009 | 82.91M | 32.43M | 64.25% |
Dec 31, 2008 | 50.48M | 25.15M | 99.26% |
Dec 31, 2007 | 25.33M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AirSculpt Technologies | 197.72M |
Nektar Therapeutics | 90.17M |
AVITA Medical | 51.50M |
Nanobiotix | 40.23M |
Zevra Therapeutics | 28.01M |
Senseonics Holdings | 23.30M |
Profound Medical | 5.33M |
Atai Life Sciences | 277.00K |
CDXS News
- 3 days ago - Codexis to Report Second Quarter 2024 Financial Results on August 8 - GlobeNewsWire
- 20 days ago - Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets - GlobeNewsWire
- 2 months ago - Codexis to Participate in Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Codexis to Participate in TD Cowen 2nd Annual Sustainability Week - GlobeNewsWire
- 2 months ago - Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting - GlobeNewsWire
- 3 months ago - Codexis to Report First Quarter 2024 Financial Results on May 2 - GlobeNewsWire
- 3 months ago - Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board - GlobeNewsWire
- 5 months ago - Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results - GlobeNewsWire